A critical breakthrough in cancer research is occurring with the use of mini-antibodies to reactivate damaged p53. This vital malignant protector protein is frequently disabled in various types of tumors, leading https://mediajx.com/story309726/mini-antibodies-reactivate-the-p53-protein-a-new-pathway-for-cancer-treatment